GREY:TSTIF - Post by User
Comment by
StocksFTBon Jun 24, 2017 1:24pm
![](https://assets.stockhouse.com/kentico-cms/0342-00/images/Sprite.svg#id_Post_Views_Icon)
142 Views
Post# 26401383
RE:RE:RE:RE:Congrats Echo and shame on rumble
RE:RE:RE:RE:Congrats Echo and shame on rumble MustangSalley- I am not suggesting they hold onto options to be cheerleaders, I am suggesting that if the management team believed the statements they make on their conference calls I find it strange that the CEO continues to exercise and sell options ahead of this current FDA submission which they claim should be approved by the end of 2017. His options do not expire until midway through 2018, a rational investor and the CEO of a company should realize that it sends a horrible message when you sell stock during such a period of time. And since you brought it up now I am also curious as to how you value the stock? What are your assumptions for units sold, cycles per day, gross margins, earnings, etc. What is your blended GM assumption when you take capital equipment and consumables into account? What does your DCF suggest the stock is worth? What discount rate do you use to value the shares?